US Stem Cell Inc (USRM)

[andyshow]

This is a Biotech stock in the field of Regenerative Medicine, dilution is expected. The bigger picture is, Stem Cell therapies are becoming more and more a reality. At this point IMO "Big Pharma" and the FDA have no choice but to play ball. As someone stated previously, regardless of dilution... Stock still undervalued, IMO. Do not let the 10K holy grail expectation make us forget all the recent positive steps this company has taken moving forward. If I remember correctly, in the most recent PR about Mirror it was stated that enrollment would take 1 year putting the end time frame at July this year... 4 months away. I'm waiting for news until then, and meanwhile more steps moving forward on other projects such as the Angel Phase 1 completion. GLTA and remember regardless off the urge to focus on the photo... Take a step back and look at the Big Picture. Go BHRT!